| Application no. and date | 16741212.1 (espacenet) (Federated) (European Patent Register), 20160706 | | Patent/reg. no. and date | DK/EP 3319995, 20190417 | | Publication date | 20180516 | | Priority no. and date | US 201562189610 P, 20150707 | | EP pub. no. and date |
EP 3319995 20180516 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | P68733DK01 | | Inventor | SAMPATH, Deepak, 1 DNA Way
South San Francisco, California 94080, US,
PHILLIPS, Gail Lewis, 1 DNA Way
South San Francisco, California 94080, US,
WERTZ, Ingrid, 1 DNA Way
South San Francisco, California 94080, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/32 (2006.01) , G01N 33/574 (2006.01) | | Title | Kombinationsterapi med et anti-HER2-antistof-lægemiddelkonjugat og en bcl-2-inhibitor | | Int. application no. | US2016041184 | | Int. publication no. | WO2017007846 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
